Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1376158 | Bioorganic & Medicinal Chemistry Letters | 2008 | 5 Pages |
Abstract
4-(1,1-Dioxo-1,4-dihydro-1λ6-benzo[1,4]thiazin-3-yl)-5-hydroxy-2H-pyridazin-3-one analogs were discovered as a novel class of inhibitors of HCV NS5B polymerase. Structure-based design led to the identification of compound 3a that displayed potent inhibitory activities in biochemical and replicon assays (1b IC50 < 10 nM; 1b EC50 = 1.1 nM) as well as good stability toward human liver microsomes (HLM t1/2 > 60 min).
Graphical abstractFigure optionsDownload full-size imageDownload as PowerPoint slide
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
David A. Ellis, Julie K. Blazel, Stephen E. Webber, Chinh V. Tran, Peter S. Dragovich, Zhongxiang Sun, Frank Ruebsam, Helen M. McGuire, Alan X. Xiang, Jingjing Zhao, Lian-Sheng Li, Yuefen Zhou, Qing Han, Charles R. Kissinger, Richard E. Showalter,